Please login to the form below

Not currently logged in
Email:
Password:

Aridhia names Chris Roche as CEO

He joined the company in 2014 as chief commercial officer

edit-Chris-Roche_Aridhia-LandscapeHealth informatics firm Aridhia has named Chris Roche as CEO, succeeding co-founder David Sibbald.

Roche joined the company in 2014 as chief commercial officer and has brought a new commercial focus to the firm as Aridhia evolved into a software as a service (SaaS) based business model.

Commenting on his appointment, Roche said: “Aridhia is a rare company that has a real opportunity to change the way we use data and analytics to manage chronic disease and accelerate collaborative research. 

“I am truly honoured to be part of that story. My focus is now to accelerate our own business model by opening international hubs and building specific disease focused solutions with our clinical partners.”

Prior to joining Aridhia, Roche held multiple positions at EMC over eight years including Ireland country manager and regional director.

Roche is to replace David Sibbald, co-founder of Aridhia, will take up the role of executive chairman of the company.

Sibbald added: “During this critical time of growth, there is no better person to lead Aridhia than Chris Roche.

“Chris is a proven leader with a deep understanding of data science, business vision and the ability to bring people together. His ability to rapidly scale data businesses and corporate experience is precisely what Aridhia needs as we enter our next chapter of innovation and growth.”

12th May 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics